Aytu BioPharma, Inc. (LON:0A8M)

London · Delayed Price · Currency is GBP · Price in USD

2.200

+0.520 (30.95%)

At close: May 16, 2025

Revenue by Product

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2009 - 2019
Rx	65.18M	Log In	Log In	Log In	Log In	Upgrade
Rx Growth	-11.67%	Log In	Log In	Log In	Log In	Upgrade
Consumer Health	15.82M	Log In	Log In	Log In	Log In	Upgrade
Consumer Health Growth	-52.92%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2009 - 2019
United States	80.91M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-24.32%	Log In	Log In	Log In	Log In	Upgrade
International	91.00K	Log In	Log In	Log In	Log In	Upgrade
International Growth	-81.08%	Log In	Log In	Log In	Log In	Upgrade